tradingkey.logo

Clearpoint Neuro Inc

CLPT
13.460USD
+0.890+7.08%
終値 02/06, 16:00ET15分遅れの株価
382.64M時価総額
損失額直近12ヶ月PER

Clearpoint Neuro Inc

13.460
+0.890+7.08%

詳細情報 Clearpoint Neuro Inc 企業名

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.

Clearpoint Neuro Incの企業情報

企業コードCLPT
会社名Clearpoint Neuro Inc
上場日Jul 03, 2019
最高経営責任者「CEO」Burnett (Joseph Michael)
従業員数115
証券種類Ordinary Share
決算期末Jul 03
本社所在地120 S. Sierra Avenue
都市SOLANA BEACH
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号92075
電話番号19499006833
ウェブサイトhttps://www.clearpointneuro.com/
企業コードCLPT
上場日Jul 03, 2019
最高経営責任者「CEO」Burnett (Joseph Michael)

Clearpoint Neuro Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.33K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
79.75K
+884.00%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+21093.00%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.47K
+386.00%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-10200.00%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
276.33K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
79.75K
+884.00%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
50.52K
+21093.00%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
44.47K
+386.00%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
40.90K
-10200.00%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Products: Functional neurosurgery
3.42M
38.62%
Services: Biologics and drug delivery
3.11M
35.10%
Products: Biologics and drug delivery
1.29M
14.58%
Product Systems and software products
647.00K
7.30%
Services: Capital equipment and other
390.00K
4.40%
地域別USD
会社名
収益
比率
United States
8.86M
100.00%
事業別
地域別
事業別USD
会社名
収益
比率
Products: Functional neurosurgery
3.42M
38.62%
Services: Biologics and drug delivery
3.11M
35.10%
Products: Biologics and drug delivery
1.29M
14.58%
Product Systems and software products
647.00K
7.30%
Services: Capital equipment and other
390.00K
4.40%

株主

更新時刻: Fri, Feb 6
更新時刻: Fri, Feb 6
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
5.94%
BlackRock Institutional Trust Company, N.A.
5.47%
Bigger Capital Funds, LP
4.48%
PTC Therapeutics Inc
3.01%
Geode Capital Management, L.L.C.
2.21%
他の
78.90%
株主統計
株主統計
比率
The Vanguard Group, Inc.
5.94%
BlackRock Institutional Trust Company, N.A.
5.47%
Bigger Capital Funds, LP
4.48%
PTC Therapeutics Inc
3.01%
Geode Capital Management, L.L.C.
2.21%
他の
78.90%
種類
株主統計
比率
Investment Advisor
21.26%
Investment Advisor/Hedge Fund
10.48%
Hedge Fund
8.69%
Individual Investor
4.99%
Corporation
3.01%
Research Firm
1.38%
Bank and Trust
0.10%
Pension Fund
0.03%
Insurance Company
0.03%
他の
50.03%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
238
11.91M
42.82%
-795.00
2025Q3
241
11.91M
44.93%
+805.07K
2025Q2
228
11.11M
37.29%
+1.29M
2025Q1
216
9.82M
36.04%
-268.85K
2024Q4
204
9.20M
33.04%
+1.04M
2024Q3
190
8.15M
32.05%
-235.56K
2024Q2
185
8.39M
33.08%
-454.38K
2024Q1
183
8.85M
30.95%
+359.48K
2023Q4
183
7.82M
35.41%
+717.11K
2023Q3
184
7.11M
35.71%
+336.40K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
1.50M
5.03%
+22.52K
+1.53%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.63M
5.47%
+127.17K
+8.48%
Sep 30, 2025
Bigger Capital Funds, LP
1.29M
4.34%
+126.00K
+10.80%
Sep 30, 2025
PTC Therapeutics Inc
894.58K
3.01%
--
--
Aug 23, 2024
Geode Capital Management, L.L.C.
656.40K
2.21%
+31.60K
+5.06%
Sep 30, 2025
State Street Investment Management (US)
482.65K
1.62%
+149.27K
+44.77%
Sep 30, 2025
Two Sigma Investments, LP
442.93K
1.49%
+421.00K
+1919.91%
Sep 30, 2025
Bigger (Michael)
378.69K
1.27%
--
--
Sep 30, 2025
UBS Financial Services, Inc.
360.70K
1.21%
+205.29K
+132.10%
Sep 30, 2025
District 2 Capital LP
307.75K
1.03%
-122.42K
-28.46%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Invesco NASDAQ Future Gen 200 ETF
1.19%
iShares Neuroscience and Healthcare ETF
0.94%
iShares Micro-Cap ETF
0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.09%
Vanguard US Momentum Factor ETF
0.06%
Motley Fool Next Index ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
iShares Russell 2000 ETF
0.02%
Proshares Ultra Russell 2000
0.02%
詳細を見る
Invesco NASDAQ Future Gen 200 ETF
比率1.19%
iShares Neuroscience and Healthcare ETF
比率0.94%
iShares Micro-Cap ETF
比率0.12%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.09%
Vanguard US Momentum Factor ETF
比率0.06%
Motley Fool Next Index ETF
比率0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
比率0.03%
iShares Russell 2000 Growth ETF
比率0.03%
iShares Russell 2000 ETF
比率0.02%
Proshares Ultra Russell 2000
比率0.02%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI